A biotech company is suing a prostate cancer researcher for making false claims concerning a disease biomarker, reports Science Insider. According to the Pittsburgh Tribune-Review, Robert Getzenberg, then at University of Pittsburgh and now at Johns Hopkins University, he found a biomarker, EPCA-2, for human prostate cancer that he and the University of Pittsburgh patented it.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.